4377

antibody from Cell Signaling Technology, Inc

Targeting: MAPK3 ERK1, p44erk1, p44mapk, PRKM3

Western blot (Data presented on provider website)

Immunocytochemistry (Data presented on provider website)

Flow cytometry (Data presented on provider website)

Antibody Data

Product number

4377

Provider

Cell Signaling Technology, Inc

Proper citation

Cell Signaling Technology Cat#4377, RRID:AB_331775

Product name

Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204) (197G2) Rabbit mAb

Antibody type

Monoclonal

Reactivity

Human, Mouse, Rat, Drosophila, Porcine, Simian, Other

Host

Rabbit

Storage

-20°C

References

Submitted references

Differential role for CD277 as a co-regulator of the immune signal in T and NK cells.

Messal N, Mamessier E, Sylvain A, Celis-Gutierrez J, Thibult ML, Chetaille B, Firaguay G, Pastor S, Guillaume Y, Wang Q, Hirsch I, Nunès JA, Olive D
European journal of immunology 2011 Dec;41(12):3443-54

---

Developmental acquisition of the Lyn-CD22-SHP-1 inhibitory pathway promotes B cell tolerance.

Gross AJ, Lyandres JR, Panigrahi AK, Prak ET, DeFranco AL
Journal of immunology (Baltimore, Md. : 1950) 2009 May 1;182(9):5382-92

---

Acetaminophen prevents aging-associated hyperglycemia in aged rats: effect of aging-associated hyperactivation of p38-MAPK and ERK1/2.

Wu M, Desai DH, Kakarla SK, Katta A, Paturi S, Gutta AK, Rice KM, Walker EM Jr, Blough ER
Diabetes/metabolism research and reviews 2009 Mar;25(3):279-86

---

TLR3 ligand induces NF-{kappa}B activation and various fates of multiple myeloma cells depending on IFN-{alpha} production.

Chiron D, Pellat-Deceunynck C, Amiot M, Bataille R, Jego G
Journal of immunology (Baltimore, Md. : 1950) 2009 Apr 1;182(7):4471-8

---

Inhibition of mitogen-activated protein kinase phosphatase 3 activity by interdomain binding.

Mark JK, Aubin RA, Smith S, Hefford MA
The Journal of biological chemistry 2008 Oct 17;283(42):28574-83

---

Sensitization to the lysosomal cell death pathway by oncogene-induced down-regulation of lysosome-associated membrane proteins 1 and 2.

Fehrenbacher N, Bastholm L, Kirkegaard-Sørensen T, Rafn B, Bøttzauw T, Nielsen C, Weber E, Shirasawa S, Kallunki T, Jäättelä M
Cancer research 2008 Aug 15;68(16):6623-33

---

T-cell function is partially maintained in the absence of class IA phosphoinositide 3-kinase signaling.

Deane JA, Kharas MG, Oak JS, Stiles LN, Luo J, Moore TI, Ji H, Rommel C, Cantley LC, Lane TE, Fruman DA
Blood 2007 Apr 1;109(7):2894-902

---

ShcA mediates the dominant pathway to extracellular signal-regulated kinase activation during early thymic development.

Trampont P, Zhang L, Ravichandran KS
Molecular and cellular biology 2006 Dec;26(23):9035-44

---

IL-27 induces Th1 differentiation via p38 MAPK/T-bet- and intercellular adhesion molecule-1/LFA-1/ERK1/2-dependent pathways.

Owaki T, Asakawa M, Fukai F, Mizuguchi J, Yoshimoto T
Journal of immunology (Baltimore, Md. : 1950) 2006 Dec 1;177(11):7579-87